Apparently, an antibody genetically engineered to neutralize myostatin was developed by New Jersey pharmaceutical company Wyeth. The inhibor is called MYO-029 and is currently undergoing human testing.
http://www.medicalnewstoday.com/medicalnews.php?newsid=20441
Anybody have any insider info about this?
http://www.medicalnewstoday.com/medicalnews.php?newsid=20441
Anybody have any insider info about this?

Please Scroll Down to See Forums Below 










